The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global gold nanoparticles market reached a value of US$ 3.76 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 12.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.
Gold nanoparticles, represented as AuNPs, are gold particles with a diameter of 1 to 100 nanometers (nm). They are majorly used in biomedical and biotechnological sciences for their large surface area and bio-inertness. They also have high electron conductivity, stability and solubility. These particles are manufactured in the form of nanospheres, nanocages, nanorods, nanoshells, nanocubes and nanoclusters and find extensive application in targeted drug administration and as agents in biomolecules delivery. Gold nanoparticles are also utilized as optical imaging probes for detection of biomarkers of various diseases and in imaging procedures such as positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound scans.
The growing medical industry, along with the growing demand for nanotechnological medical products, represent as the key factors driving the growth of the market. Gold nanoparticles are increasingly being used in the medical industry, especially in the dental sector, for various purposes including target imaging for cancer therapy and dental filling. Furthermore, the flourishing electronics industry is also significantly contributing to the market growth as these nanoparticles are extensively utilized to produce inks used in storage devices, hard disks and microchips. They are also used in the manufacturing of thin-film transistors and photo-sensors. Additionally, the food and beverage industry widely utilize colorimetric sensors that are manufactured using these particles. These sensors assist in detecting the freshness and consumability of food products. Various technological advancements, such as the development of injectable plant plastids to enhance biosynthesis and extensive research and development (R&D), are also driving the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global gold nanoparticles market report, along with forecasts for growth at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, type, application and end-use industry.
Breakup by Type:
Breakup by Application:
Breakup by End-Use Industry:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, BBI Solutions, Cline Scientific, Cytodiagnostics, Expedeon, Goldsol, Meliorum Technologies, Merck Group, Metalor Technologies International , Nanocomposix, NanoHybrids, Nanopartz, Sigma-Aldrich, Solaris Nanosciences Corporation, Tanaka Kikinzoku, etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Type, Application, End-Use Industry, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Agilent Technologies, BBI Solutions, Cline Scientific, Cytodiagnostics, Expedeon, Goldsol, Meliorum Technologies, Merck Group, Metalor Technologies International , Nanocomposix, NanoHybrids, Nanopartz, Sigma-Aldrich, Solaris Nanosciences Corporation and Tanaka Kikinzoku|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at